Scientific Laboratory Supplies’ acquisition of C&M will bolster the company’s scientific calibration, maintenance, and validation offerings.
Scientific Laboratory Supplies (SLS), a supplier of laboratory equipment, materials, and supplies based in the United Kingdom, recently announced the acquisition of C&M Scientific, a scientific calibration, maintenance, and validation company also based in the UK.
According to a press release from Jan. 12, 2023, the acquisition aligns with SLS’ strategy of acquiring companies across the UK and Ireland. Operating throughout northern England and Scotland, C&M is fully accredited to ISO 9001, ISO 14001, ISO 45001, and ISO/IEC 17025 certification, and also adheres to Medicines and Healthcare products Regulatory Agency, FDA, and Good Manufacturing Practice standards.
“Our multidisciplinary service and product range combine to provide a complete solution for laboratories across Scotland and the North of England. Joining the SLS Group will help us further extend our reach and expand our product offering,” said Ian Alexander, managing director, C&M Scientific, in the release.
“We are thrilled to welcome C&M Scientific to the ever-growing SLS family,” said Ian Roulstone, managing director, SLS, in the release. “This deal represents another great addition to the SLS Group as C&M Scientific have cultivated a reputation for unrivaled technical expertise.
We are excited to further expand the SLS Group service provision and this acquisition continues our recent focus on developing a world-class service offering.”
Source: Scientific Laboratory Supplies
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.